Get started
Author

Yuan Quan

Observed names: Yin-Sheng Quan, Yin-sheng Quan, Yin‐Sheng Quan
Institution: Yanbian University
Observed institution: Yanbian University
ORCID: 0000-0003-4475-611X
Observed ORCID: 0000-0003-4475-611X
OpenAlex ID: A5100600803
Potential α-glucosidase inhibitor from Hylotelephium erythrostictum
2020 · Yin-Sheng Quan, Xiao-Yong Zhang, et al. · Bioorganic & Medicinal Chemistry Letters · 25
Design, synthesis fusidic acid derivatives alleviate acute lung injury via inhibiting MAPK/NF-κB/NLRP3 pathway
2023 · Zheng Liu, Xing Huang, et al. · European Journal of Medicinal Chemistry · 24
Application of Chalcone in the Structural Modification of Natural Products: An Overview
2024 · Yin‐Sheng Quan, Jin‐Ying Liu, et al. · Chemistry & Biodiversity · 19
Design, synthesis, and in vitro and in vivo biological evaluation of dihydroartemisinin derivatives as potent anti-cancer agents with ferroptosis-inducing and apoptosis-activating properties
2024 · Qian Xu, Hao Deng, et al. · European Journal of Medicinal Chemistry · 17
Panaxadiol carbamate derivatives: Synthesis and biological evaluation as potential multifunctional anti-Alzheimer agents
2023 · Yin-Sheng Quan, Xiaoting Li, et al. · Bioorganic Chemistry · 11
Design and synthesis of azole derivatives of echinocystic acid as α-glucosidase inhibitors with hypoglycemic activity
2025 · Hao Deng, Qian Xu, et al. · European Journal of Medicinal Chemistry · 10
In vitro and in vivo biological evaluation of newly synthesized multi-target 20(R)-panaxadiol derivatives for treating Alzheimer's disease
2022 · Lei Pang, Jin Li, et al. · European Journal of Medicinal Chemistry · 9
Recent advances in structural modifications of natural products for anti-leishmaniasis therapy (2010–2024)
2025 · Fu-Qun Sun, Yin-Sheng Quan, et al. · RSC Medicinal Chemistry · 8
PDF
A review of developments in glycogen synthase kinase-3 regulators over the past 10 years
2025 · Ya-lan Wang, Ke Sun, et al. · Biochemical Pharmacology · 7
Synthesis, Evaluation of Anti-Toxoplasma gondii Activity in vitro and Molecular Docking of Dihydroartemisinin Derivatives
2022 · Hao Deng, Zheng-Ai Chen, et al. · Pharmaceutical Chemistry Journal · 6
Discovery of oleanolic acid derivatives that inhibit tau protein phosphorylation and neuroinflammation induced by Aβ25–35 in vitro and in vivo
2025 · Zheng Liu, Xing Huang, et al. · Bioorganic Chemistry · 4
Structural diversification and selective inhibition of HDAC3: A comprehensive review of inhibitors and degraders
2026 · Jin-ying Liu, Yin-sheng Quan, et al. · European Journal of Medicinal Chemistry · 2
Recent Advancements in Pentacyclic and Other Terpenoid Derivatives as Anti-inflammatory Agents
2025 · Yun-Xia Sun, Qing-Kun Shen, et al. · Mini-Reviews in Medicinal Chemistry · 1
Design synthesis and evaluation of usnic acid derivatives as multi-target drugs for Alzheimer's disease
2026 · Yin-Sheng Quan, Jin-Ying Liu, et al. · Bioorganic Chemistry
Corrigendum to “Discovery of chalcone-1,2,4-triazole derivatives with potent anti-tumor activity targeting Bcl-2: In vitro and in vivo evaluation” [Bioorg. Chem. 169 (2026) 109371]
2026 · Yin-Sheng Quan, Hui Liu, et al. · Bioorganic Chemistry
Discovery of chalcone-1,2,4-triazole derivatives with potent anti-tumor activity targeting Bcl-2: In vitro and in vivo evaluation
2025 · Yin-Sheng Quan, Hui Liu, et al. · Bioorganic Chemistry
Author response for "Recent Advances in Structural Modifications of Natural Products for Anti-Leishmaniasis Therapy (2010-2024)"
2025 · Fu-Qun Sun, Yin-Sheng Quan, et al. · Publons reviews and discussion
Works count: 17
Citation count: 143
H-index: 8
I10-index: 6
Year
Topic
Type